TD Cowen Has Lowered Expectations for DaVita (NYSE:DVA) Stock Price

DaVita (NYSE:DVA) had its price target decreased by analysts at TD Cowen from $154.00 to $133.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. TD Cowen’s target price indicates a potential upside of 13.53% from the company’s previous close.

A number of other brokerages have also commented on DVA. Weiss Ratings reissued a “hold (c+)” rating on shares of DaVita in a report on Wednesday, October 8th. Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Truist Financial set a $140.00 price target on DaVita in a research report on Tuesday, October 14th. Zacks Research cut DaVita from a “hold” rating to a “strong sell” rating in a research note on Thursday. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research note on Monday. Five research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $148.00.

DaVita Price Performance

Shares of DVA traded down $1.87 during trading hours on Monday, hitting $117.15. The stock had a trading volume of 196,593 shares, compared to its average volume of 840,546. DaVita has a 1-year low of $115.39 and a 1-year high of $179.60. The firm has a market capitalization of $8.38 billion, a P/E ratio of 12.06, a price-to-earnings-growth ratio of 0.91 and a beta of 1.13. The firm has a 50 day simple moving average of $130.78 and a 200-day simple moving average of $136.56.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $2.51 EPS for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). DaVita had a net margin of 5.80% and a return on equity of 815.62%. The business had revenue of $3.42 billion for the quarter, compared to the consensus estimate of $3.43 billion. During the same quarter last year, the firm posted $2.59 EPS. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. Equities analysts predict that DaVita will post 10.76 EPS for the current fiscal year.

Hedge Funds Weigh In On DaVita

Several institutional investors and hedge funds have recently bought and sold shares of DVA. Concurrent Investment Advisors LLC bought a new position in DaVita during the 1st quarter worth approximately $223,000. Envestnet Asset Management Inc. grew its holdings in DaVita by 7.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company’s stock worth $8,452,000 after acquiring an additional 4,048 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new stake in DaVita in the 1st quarter worth approximately $200,000. Teacher Retirement System of Texas purchased a new position in DaVita during the 1st quarter valued at $1,010,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in DaVita in the 1st quarter worth $364,000. 90.12% of the stock is owned by institutional investors.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.